Cargando…
Healthy ageing: Herpes zoster infection and the role of the adjuvanted recombinant zoster vaccine
BACKGROUND: Increases in life expectancy over the last 50 years has been matched by an increase in the burden of diseases (e.g. herpes zoster (HZ)) in adults ≥50 years of age (YOA). Without intervention, around 30% of individuals can expect to develop HZ in their lifetime, which would impact their d...
Autores principales: | Curran, D, Doherty, TM, Lecrenier, N, Breuer, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594383/ http://dx.doi.org/10.1093/eurpub/ckac131.013 |
Ejemplares similares
-
Healthy ageing: Herpes zoster infection and the role of zoster vaccination
por: Curran, Desmond, et al.
Publicado: (2023) -
The impact of the COVID-19 pandemic on the incidence of herpes zoster: Nicolas Lecrenier
por: Lecrenier, N, et al.
Publicado: (2022) -
20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
por: Curran, Desmond, et al.
Publicado: (2021) -
12. Modeled Impact of the COVID-19 Pandemic and Associated Reduced Adult Vaccinations on Herpes Zoster in the United States
por: La, Elizabeth M, et al.
Publicado: (2021) -
An update on national recommendations for the use of the adjuvanted recombinant zoster vaccine: Romy Weller
por: Parikh, R, et al.
Publicado: (2022)